Pharmaceuticals

Quintiles Goes Public, Sets Share Price At $40

Leoneda Inge — Thu, 09 May 2013 12:12:05 +0000

Trading on the New York Stock Exchange begins Thursday for North Carolina-based Quintiles.

The company announced late Wednesday that it is selling about 23.7 million shares of its common stock to the public at $40 a share. That would raise nearly $950 million in this initial public offering for the bio-pharmaceutical services company.

System To Track Prescription Drugs Underused

Catherine Brand — Thu, 28 Mar 2013 09:00:00 +0000

Prescription drug overdose kills an average of three people per day in North Carolina.

Researchers at UNC Chapel Hill say a statewide system designed to reduce those numbers – North Carolina Controlled Substances Reporting System (CSRS) – is effective - but grossly underused.

CSRS went into effect in 2007, following a legislative mandate, but of the 34,000 providers authorized to prescribe controlled substances, only a third have registered with the CSRS, and fewer than half of those actually use it.

Drug Database Gets Little Use From Pharmacists

Gurnal Scott — Mon, 26 Nov 2012 23:15:00 +0000

State health officials want to know if low use of a prescription drug database is leading to more deaths in North Carolina.

GSK Recycling Inhalers

Colleen Vasu — Thu, 25 Oct 2012 10:00:00 +0000

Drug maker GlaxoSmithKline is beginning a program to recycle spent respiratory inhalers. The company is signing up pharmacies in the Raleigh-Durham area and 30 other cities to collect the breathing aids. The company tested the program in a few of the selected cities and collected about 27-hundred inhalers. GSK's vice presider for respiratory business Jorge Bartolome says the "Complete the Cycle" program will break down the inhalers for multiple uses.

Duke Study Calls For More Children's Drug Trials

Gurnal Scott — Mon, 01 Oct 2012 09:00:00 +0000

Duke University doctors say clinical trials on how drugs affect children are few and far between. Gurnal Scott reports.

Doctors looked at research conducted from 2005 to 2010 -- about 60-thousand trials. They found that adult medical trials far outnumber ones on kids under 18.

"By about 10 to one," says one of the study's writers, Alex Kemper, a pediatrics professor at Duke. "For those of us who provide care to children, we know that clinical trials are the best way to know how to treat conditions.

NC-Based PPD Sold

Leoneda Inge — Tue, 04 Oct 2011 14:00:00 +0000

North Carolina’s clinical trials industry is seeing a major shift. The latest example is the purchase of Wilmington-based P-P-D.

Drug Maker Working on Smallpox Treatment

Jeremy Loeb — Fri, 18 Feb 2011 10:00:00 +0000

The federal government has awarded drug maker Chimerix a nearly $25 million grant to develop an anti-viral drug for smallpox.

The Durham-based company’s lead candidate is a drug called CMX001. Chimerix President and CEO Kenneth Moch says the government wants the treatment ready in case of a smallpox outbreak as the result of a bioterrorist attack.